Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
devices for critical care and surgery, announced that a newly published
clinical study demonstrates that the accuracy of the ARROW ®
VPS G4™ Vascular Positioning System, with placements of peripherally
inserted central catheters (PICCs), can eliminate the use of
confirmatory chest X-rays.
for The ARROW® VPS G4™ Device, a Vascular Positioning System from Teleflex, Streamlines Placement of Central IV Catheters, Study Reports investment picks